Clinical Trials Logo

Clinical Trial Summary

The investigators plan to retrospectively analyze clinical data from 14,189 fresh ICSI cycles in Reproductive and Genetic Hospital of CITIC-Xiangya from January 2016 to December 2017.The investigators will regard total progressive sperm number of 2 x 10^6 after pretreatment as the boundary value, and will divide total progressive sperm number of 2 x 10^6 after pretreatment into 2 x 10^6 or higher and < 2 x 10^6 groups, and will further divide < 2 x 10^6 group into: = 0, (0,10^6], (10^6, 2 x 10^6) three groups. Propensity score matching will be used to balance the baseline data between four groups. The matching variables are age, female BMI, AFC, AMH and ICSI.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03594201
Study type Observational
Source Reproductive & Genetic Hospital of CITIC-Xiangya
Contact
Status Completed
Phase
Start date January 1, 2016
Completion date January 3, 2018

See also
  Status Clinical Trial Phase
Completed NCT02935738 - Prednisolone Improves IVF Outcomes in Men With Anti-sperm Antibodies N/A
Not yet recruiting NCT06193135 - Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitary Suppression With Medroxiprogesterona Acetate (MPA) N/A
Withdrawn NCT03191890 - Post Market Surveillance & Post Market Clinical Follow up, International, Medical Registry to Confirm the Safety and the Performance of the Anecova Intra Uterine Culture Device
Completed NCT06330259 - Does the AMH Concentration Depend on the Menstrual Cycle?
Recruiting NCT05181748 - Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders Phase 2/Phase 3
Terminated NCT02652143 - Does in Vivo Culture of Pre-cleavage Stage Embryo Reduce the Incidence of Aneuploidy? N/A
Completed NCT05184777 - Evaluation of Salivary ELISA for Hormone Monitoring in IVF Patients N/A
Recruiting NCT05780489 - Evaluation of Salivary ELISA for Hormone Monitoring in Donors N/A